Tyra Biosciences Inc (TYRA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.38B
Last updated: Nov 17, 2026 at 11:06 AM ET
Tyra Biosciences Inc (TYRA) Earnings: Report Dates and Results
Tyra Biosciences (TYRA) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Tyra Biosciences reported EPS of -$0.74, below the -$0.66 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TYRA has an expected report date of Mar 1, 2027.
Earnings History
Of the 21 quarters below that had an estimate, TYRA beat 9, missed 11 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 80.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.74 | -$0.66 | -$0.76 - -$0.47 | -12.12% | Miss | N/A | 14 | 2 up, 0 down | Nov 10, 2026 |
| Jun 30, 2026 | -$0.69 | -$0.67 | -$0.70 - -$0.56 | -2.99% | Miss | N/A | 14 | 1 up, 0 down | Aug 4, 2026 |
| Mar 31, 2026 | -$0.64 | -$0.58 | -$0.64 - -$0.56 | -10.34% | Miss | N/A | 10 | 1 up, 4 down | May 13, 2026 |
| Dec 31, 2025 | -$0.57 | -$0.53 | -$0.63 - -$0.46 | -7.55% | Miss | N/A | 9 | 1 up, 0 down | Mar 2, 2026 |
| Sep 30, 2025 | -$0.50 | -$0.50 | -$0.60 - -$0.47 | 0.00% | In line | N/A | 5 | 2 up, 0 down | Nov 5, 2025 |
| Jun 30, 2025 | -$0.47 | -$0.51 | -$0.58 - -$0.46 | +7.84% | Beat | N/A | 5 | 1 up, 2 down | Aug 14, 2025 |
| Mar 31, 2025 | -$0.47 | -$0.48 | -$0.56 - -$0.41 | +2.08% | Beat | N/A | 4 | 0 up, 1 down | May 8, 2025 |
| Dec 31, 2024 | -$0.43 | -$0.48 | -$0.56 - -$0.37 | +10.42% | Beat | N/A | 6 | 1 up, 4 down | Mar 27, 2025 |
| Sep 30, 2024 | -$0.41 | -$0.39 | -$0.45 - -$0.35 | -5.13% | Miss | N/A | 7 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$0.32 | -$0.39 | -$0.46 - -$0.36 | +17.95% | Beat | N/A | 6 | 0 up, 0 down | Aug 7, 2024 |
| Mar 31, 2024 | -$0.35 | -$0.46 | -$0.53 - -$0.42 | +23.91% | Beat | N/A | 6 | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$0.53 | -$0.48 | -$0.55 - -$0.43 | -10.42% | Miss | N/A | 6 | 0 up, 0 down | Mar 19, 2024 |
| Sep 30, 2023 | -$0.49 | -$0.35 | -$0.40 - -$0.31 | -40.00% | Miss | N/A | 6 | 0 up, 0 down | Nov 7, 2023 |
| Jun 30, 2023 | -$0.31 | -$0.34 | -$0.42 - -$0.29 | +8.82% | Beat | N/A | 6 | 0 up, 0 down | Aug 10, 2023 |
| Mar 31, 2023 | -$0.28 | -$0.37 | -$0.43 - -$0.28 | +24.32% | Beat | N/A | 5 | 1 up, 0 down | May 4, 2023 |
| Dec 31, 2022 | -$0.31 | -$0.36 | -$0.40 - -$0.34 | +13.89% | Beat | N/A | 5 | 0 up, 0 down | Mar 22, 2023 |
| Sep 30, 2022 | -$0.30 | -$0.39 | -$0.45 - -$0.37 | +23.08% | Beat | N/A | 4 | 0 up, 0 down | Nov 3, 2022 |
| Jun 30, 2022 | -$0.36 | -$0.30 | N/A | -20.00% | Miss | N/A | N/A | 0 up, 0 down | Aug 4, 2022 |
| Mar 31, 2022 | -$0.36 | -$0.20 | -$0.20 - -$0.20 | -80.00% | Miss | N/A | 2 | 0 up, 0 down | May 5, 2022 |
| Dec 31, 2021 | -$0.24 | -$0.21 | -$0.24 - -$0.19 | -14.29% | Miss | N/A | 3 | N/A | Mar 3, 2022 |
| Sep 30, 2021 | -$0.72 | -$0.60 | N/A | -20.00% | Miss | N/A | 2 | N/A | Nov 3, 2021 |
| Jun 30, 2021 | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 15, 2021 |
| Mar 31, 2021 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 28, 2021 |
| Dec 31, 2020 | -$2.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 |
| Sep 30, 2020 | -$1.80 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2020 |
| Jun 30, 2020 | -$1.80 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 |
| Mar 31, 2020 | -$1.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2020 |
| Dec 31, 2019 | -$1.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.01, after -$1.51 the year before. It was -$1.07 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.01 | N/A |
| Dec 31, 2024 | -$1.51 | N/A |
| Dec 31, 2023 | -$1.61 | N/A |
| Dec 31, 2022 | -$1.33 | N/A |
| Dec 31, 2021 | -$1.24 | N/A |
| Dec 31, 2020 | -$6.97 | N/A |
| Dec 31, 2019 | -$1.07 | N/A |
Frequently Asked Questions About TYRA
When is Tyra Biosciences's next earnings date?
Tyra Biosciences's next earnings report is expected for Mar 1, 2027.
Did TYRA beat earnings estimates last quarter?
No. Tyra Biosciences reported EPS of -$0.74 for the quarter ended Sep 30, 2026, below the -$0.66 estimate by 12.12%.
What EPS do analysts expect from TYRA next quarter?
The consensus EPS estimate for Tyra Biosciences for the quarter ending Dec 31, 2026 is -$0.72 from 17 analysts, with estimates from -$0.77 to -$0.59.
How often does TYRA beat earnings estimates?
Tyra Biosciences beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -1.58%.
TYRA pages: Overview, Earnings, Forecast, Financials, Competitors